The role of CD44 in pathological angiogenesis

FASEB J. 2020 Oct;34(10):13125-13139. doi: 10.1096/fj.202000380RR. Epub 2020 Aug 23.

Abstract

Angiogenesis is required for normal development and occurs as a pathological step in a variety of disease settings, such as cancer, ocular diseases, and ischemia. Recent studies have revealed the role of CD44, a widely expressed cell surface adhesion molecule, in promoting pathological angiogenesis and the development of its associated diseases through its regulation of diverse function of endothelial cells, such as proliferation, migration, adhesion, invasion, and communication with the microenvironment. Conversely, the absence of CD44 expression or inhibition of its function impairs pathological angiogenesis and disease progression. Here, we summarize the current understanding of the roles of CD44 in pathological angiogenesis and the underlying cellular and molecular mechanisms.

Keywords: CD44; HA; angiogenesis; cancer; ischemia; ocular disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Hyaluronan Receptors / genetics
  • Hyaluronan Receptors / metabolism*
  • Neovascularization, Pathologic / metabolism*
  • Signal Transduction

Substances

  • Hyaluronan Receptors